Chou Kathryn K. sold $152K of IONQ

Chou Kathryn K. sold 2,757 shares of IonQ, Inc. (IONQ) at $55.02 ($0.15M total) on 2026-06-18 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Chou Kathryn K.
Published Jun 23, 2026, 1:55 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 23, 2026, 2:02 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IONQ
Neutral
high confidence
Mentioned
$IONQ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IONQNeutralLow
01

Why it matters

Insider sales can affect short-term sentiment, but 10b5-1 plans are designed to reduce timing-based inference.

02

Market read

A director’s disclosed sale of ~$151.7K is unlikely to drive fundamentals, but may slightly influence sentiment around insider activity.

03

What to watch

The filing does not indicate intent beyond the plan; without additional context (e.g., other concurrent insider buys/sales, changes in options holdings), the signal is weak.

Relevance 3/10Novelty 3/10Timing: Filed 2026-06-22 for a 2026-06-18 sale (insider transaction disclosure).

Background

The article is an SEC Form 4 insider transaction: director Kathryn K. Chou sold shares of IonQ under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$IONQNeutralHigh confidence
Context

IonQ director Kathryn K. Chou sold 2,757 shares in an open-market transaction for about $151.7K under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect would be sentiment-only unless paired with other new catalysts.

Evidence & confidence

Form 4 details a small-to-moderate dollar sale by a director and explicitly notes a pre-arranged 10b5-1 plan, which typically reduces interpretive signal.

Market effects

No clear sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still coincide with internal caution; traders may watch for follow-on sales or other filings.

Key entities

  • IonQ, Inc.

    Issuer of the Form 4 insider sale disclosure.

  • Kathryn K. Chou

    Director who executed an open-market sale of 2,757 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IONQMedAI 8/10

What IonQ (IONQ) Said on Its Q3 Earnings Call

IonQ reported Q3 earnings, highlighting partnerships with NVIDIA, SDT, and others. The company secured a $33M contract with SDT and saw $1.2B in remaining performance obligations. SkyWater's quantum foundry revenue grew over 30% YoY. IonQ reported an adjusted EBITDA loss of $133.6M but raised $2B in October, bringing cash balance to $3.7B. The company aims for profitability while maintaining growth.

$IONQHighAI 8/10

IonQ raises its 2026 revenue forecast to $505-$515 million

IonQ reported Q3 revenue of $173.8M, up 336% YoY, and raised its 2026 revenue forecast to $505M-$515M. The company's quantum computing revenue is expected to grow 110% this year. Shares rose 3% in after-hours trading and 21.5% the following day. IonQ's growth was driven by its quantum hardware and chip foundry, acquired in July.

$IONQMedAI 8/10

IonQ Publishes Q3 2026 Earnings Call Transcript

IonQ raised its 2026 revenue forecast to $505M-$515M from $450M-$460M. Q3 revenue rose 336% to $173.8M, including $83.5M from SkyWater. Management reported $1.2B in remaining performance obligations, with $290M in new contracts. Superion 256 capacity for 2027 is sold out. IonQ advanced to the final stage of DARPA's Quantum Benchmarking Initiative, worth up to $300M.